Comparison

Caffeic acid European Partner

Item no. HY-N0172-10mM
Manufacturer MedChem Express
CASRN 331-39-5
Amount 10 mM/1 mL
Quantity options 100 mg 10g 10 mM/1 mL 25 g 5 g
Category
Type Inhibitors
Specific against other
Purity 99.47
Formula C9H8O4
Citations [1]Pradhananga S, et al. Caffeic acid exhibits anti-pruritic effects by inhibition of multiple itch transmission pathways in mice. Eur J Pharmacol. 2015 Sep 5;762:313-21.
[2]Liang G, et al. The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats. Behav Brain Funct. 2015 Apr 18;11:18.
Smiles O=C(O)/C=C/C1=CC=C(O)C(O)=C1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 331-39-5
Shipping condition Room temperature
Available
Manufacturer - Type
Natural Products
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Endogenous Metabolite; Lipoxygenase; TRP Channel
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
180.159
Product Description
Caffeic acid is an inhibitor of both TRPV1 ion channel and 5-Lipoxygenase (5-LO).
Manufacturer - Research Area
Inflammation/Immunology; Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic)
Manufacturer - Pathway
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Isoform
5-LOX
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mM/1 mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close